My Companies
Notification
Account
Log Out
Back

Asston Pharmaceuticals Board Approves ₹27.7 Crore Preferential Issue To Non-Promoters

2 July 2026
Asston Pharmaceuticals Ltd.

Board approved preferential issue of up to 24.10 lakh equity shares at Rs 115 per share aggregating ~27.7 Cr to non-promoter allottees, subject to shareholder approval. EGM set for 31 July 2026.

Recent Events

No recent events

No events have occurred recently

Real time WhatsApp alerts using AI.

Get features of

  • Instant Notifications
  • Competitive Advantage
  • Critical Alerts
Signup or Sign in

Company Information